ARCHIVES

Cooperative Groups Advised to Prepare for 10 Percent Budget Cut, Begin Slowing Patient Accrual. Groups Say Cuts Would Jeopardize Clinical Trials Program.

This article is from The Cancer Letter archive.

Vol. 32 No. 38 | October 27, 2006

Download PDF Visit The Full Archive

Related Articles

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

February 20, 1998

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005

Deluge Of SBIR Contract Proposals Changes Picture at NCI, Could Save $5 Million For Cancer

April 12, 1985

NCI sponsors Year-Round Shannon Awards Program

April 4, 1996

Patient Advocacy: Prostate Cancer coalition Is Formed

September 6, 1996

FDA Reaction to DCT Proposals ‘Positive,’ But Chabner, Wittes ‘Disappointed’ In That Response

June 17, 1988